Advertisement

Braskem S.A. BAK

Set alert

Price alert · BAK

All alert types
1.16 USD 0.00 0.00%

At close

1.13 -0.03 -2.59%

Pre-market · Nov 2, 7:10 AM ET

Bid
1.16 × 4,500
Ask
1.18 × 1,900
1.06 Day range 1.17
0.92 52-week range 5.40
YTD
-60.68%
1 year
-53.97%
Open
1.15
Prev close
1.16
Mkt cap
462.24M
Vol
2.67M
Avg vol
2.56M
EPS
-2.60
P/E
0.00
Div yield
0.00%
More statistics
Low
1.06
High
1.17
Forward P/E
9.78
Beta
0.72
Short ratio
0.00
Inst. own
4.34%
Dividend
0.00
Ex-div date
Apr 19, 2022
Earnings
Aug 6, 2026
50-d avg
3.62
200-d avg
3.37
1y target
3.64

5Y chart

Chart tools
Interval

Events in this range
  • Dec 10, 2021Dividend: 2.63074
  • Apr 19, 2022Dividend: 0.668
  • Apr 20, 2022Dividend: 0.67439
  • Sep 10, 2024Rating: JP Morgan · Neutral → Neutral
  • Sep 18, 2024Rating: UBS · Neutral → Buy
  • May 12, 2025Earnings: 0.3; estimate 0.03; surprise 900%
  • Aug 7, 2025Earnings: -0.14; estimate -0.7; surprise 80%
  • Aug 27, 2025Rating: JP Morgan · Neutral → Neutral
  • Sep 26, 2025Downgrade: UBS · Buy → Neutral
  • Nov 11, 2025Earnings: -0.02; estimate -0.48; surprise 95.83%
  • Mar 27, 2026Earnings: -0.48; estimate -0.98; surprise 51.02%
  • May 11, 2026Earnings: 0.711; estimate 0.2063; surprise 244.64%
  • Jun 26, 2026Downgrade: Citigroup · Neutral → Sell
  • Jun 30, 2026Downgrade: JP Morgan · Overweight → Neutral
  • Aug 6, 2026Earnings: —; estimate 1.21; surprise —%
Signals (74)
NameDateAgo
SMA: BearishJun 15, 20264 months ago
SMA: BullishJun 8, 20264 months ago
SMA: BearishJun 1, 20265 months ago
SMA: BearishJun 1, 20265 months ago
MACD: Sell SignalJun 1, 20265 months ago
SMA: BullishMay 11, 20265 months ago
MACD: Buy SignalMay 11, 20265 months ago
SMA: BearishMay 4, 20266 months ago
SMA: BullishApr 27, 20266 months ago
MACD: Sell SignalApr 13, 20266 months ago
SMA: BearishMar 23, 20267 months ago
RSI: OverboughtMar 2, 20268 months ago
SMA: BullishJan 5, 202610 months ago
SMA: BullishNov 10, 202511 months ago
MACD: Buy SignalNov 10, 202511 months ago
MACD: Sell SignalSep 29, 20251 year ago
SMA: BearishSep 15, 20251 year ago
SMA: BullishAug 25, 20251 year ago
SMA: BullishMay 19, 20251 year ago
SMA: BearishMay 5, 20251 year ago
SMA: BullishApr 21, 20251 year ago
SMA: BearishFeb 24, 20251 year ago
MACD: Buy SignalJan 27, 20251 year ago
SMA: BullishJan 20, 20251 year ago
RSI: OversoldDec 9, 20241 year ago
MACD: Sell SignalOct 28, 20242 years ago
SMA: BearishOct 7, 20242 years ago
SMA: BullishSep 2, 20242 years ago
MACD: Buy SignalSep 2, 20242 years ago
SMA: BearishJul 15, 20242 years ago
SMA: BullishJul 8, 20242 years ago
SMA: BearishMay 6, 20242 years ago
MACD: Sell SignalMay 6, 20242 years ago
SMA: BearishApr 15, 20242 years ago
SMA: BullishMar 11, 20242 years ago
SMA: BearishMar 4, 20242 years ago
SMA: BullishFeb 19, 20242 years ago
SMA: BullishFeb 12, 20242 years ago
MACD: Buy SignalFeb 12, 20242 years ago
MACD: Sell SignalFeb 5, 20242 years ago
SMA: BearishJan 8, 20242 years ago
SMA: BullishDec 18, 20232 years ago
MACD: Buy SignalDec 18, 20232 years ago
SMA: BearishNov 27, 20232 years ago
SMA: BullishNov 6, 20232 years ago
SMA: BearishSep 11, 20233 years ago
SMA: BullishSep 4, 20233 years ago
SMA: BearishAug 21, 20233 years ago
MACD: Sell SignalAug 14, 20233 years ago
SMA: BearishJul 17, 20233 years ago
SMA: BullishMay 8, 20233 years ago
SMA: BullishApr 24, 20233 years ago
SMA: BearishApr 17, 20233 years ago
SMA: BullishApr 10, 20233 years ago
MACD: Buy SignalMar 27, 20233 years ago
MACD: Sell SignalMar 20, 20233 years ago
MACD: Buy SignalFeb 27, 20233 years ago
MACD: Sell SignalFeb 13, 20233 years ago
MACD: Buy SignalFeb 6, 20233 years ago
MACD: Sell SignalDec 12, 20223 years ago
SMA: BearishNov 14, 20223 years ago
SMA: BullishOct 10, 20224 years ago
MACD: Buy SignalOct 10, 20224 years ago
RSI: OversoldSep 26, 20224 years ago
SMA: BearishAug 15, 20224 years ago
SMA: BullishAug 8, 20224 years ago
SMA: BearishJun 13, 20224 years ago
SMA: BearishJun 6, 20224 years ago
SMA: BullishMay 30, 20224 years ago
SMA: BullishMay 16, 20224 years ago
SMA: BearishMar 28, 20224 years ago
SMA: BullishMar 21, 20224 years ago
SMA: BearishFeb 21, 20224 years ago
SMA: BullishJan 31, 20224 years ago

Key statistics

Market cap
1.06B
Enterprise value
62.17B
Trailing P/E
0.00
Forward P/E
9.78
PEG ratio
1.46
Price / sales
0.02
Price / book
181.02
EPS (TTM)
-4.42
Beta
0.72
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-13.68%
Revenue (TTM)
66.74B
Revenue growth
-20.40%
Free cash flow
-4.83B
Total cash
5.97B
Total debt
66.82B
Return on equity
-548.76%
Shares outstanding
172.53M
Short % of float
3.33%
50-day average
3.62
200-day average
3.37

Analyst view

Consensus: buy

Buy
Price target (mean) 3.64
Ratings (0m) 8 2 buy · 6 hold · 0 sell
  • Strong buy2
  • Buy0
  • Hold6
  • Sell0
  • Strong sell0

Next earnings

Aug 6, 2026

Expected Aug 6, 2026. Consensus EPS estimate 1.68.

Earnings history

Financials — quick view

All financials
BAK Revenue — annual 70.72B
2010-FY 20102011-FY 20112012-FY 20122013-FY 20132014-FY 20142015-FY 20152016-FY 20162017-FY 20172018-FY 20182019-FY 20192020-FY 20202021-FY 20212022-FY 20222023-FY 20232024-FY 20242025-FY 2025
BAK Net income — annual -9.88B
2010-FY 20102011-FY 20112012-FY 20122013-FY 20132014-FY 20142015-FY 20152016-FY 20162017-FY 20172018-FY 20182019-FY 20192020-FY 20202021-FY 20212022-FY 20222023-FY 20232024-FY 20242025-FY 2025
BAK EPS — annual -24.79
2010-FY 20102011-FY 20112012-FY 20122013-FY 20132014-FY 20142015-FY 20152016-FY 20162017-FY 20172018-FY 20182019-FY 20192020-FY 20202021-FY 20212022-FY 20222023-FY 20232024-FY 20242025-FY 2025

Earnings

BAK recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Aug 6, 2026Jun 30, 20261.21———
May 11, 2026Mar 31, 20260.20630.711+0.50+244.64%
Mar 27, 2026Dec 31, 2025-0.98-0.48+0.50+51.02%
Nov 11, 2025Sep 30, 2025-0.48-0.02+0.46+95.83%
Aug 7, 2025Jun 30, 2025-0.70-0.14+0.56+80.00%
May 12, 2025Mar 31, 20250.030.30+0.27+900.00%

Upgrades / downgrades

BAK analyst upgrades and downgrades
DateFirmActionFromTo
Jun 30, 2026JP MorgandownOverweightNeutral
Jun 26, 2026CitigroupdownNeutralSell
Sep 26, 2025UBSdownBuyNeutral
Aug 27, 2025JP MorganmainNeutralNeutral
Sep 18, 2024UBSupNeutralBuy
Sep 10, 2024JP MorganmainNeutralNeutral

About Braskem S.A.

Braskem S.A., together with its subsidiaries, engages in the manufacture, sale, import, and export of chemicals, petrochemicals, and fuels in Brazil. The company supplies electricity and other inputs to second-generation producers; sells utilities, such as steam, water, compressed air and industrial gases; industrial services; and engages in the production, supply, and sale of electric energy and gas. It also produces and sells polyethylene, including the production of green PE made from renewable resources, and polypropylene; and polyvinyl chloride and caustic soda. In addition, the company provides thermoplastic resins; and other basic petrochemicals. It has operations in the United States, Europe, Asia, and internationally. The company was formerly known as Copene Petroquímica do Nordeste S.A. and changed its name to Braskem S.A. in 2002. Braskem S.A. was founded in 1972 and is headquartered in São Paulo, Brazil.

Sector
Basic Materials
Industry
Chemicals
Country
Brazil
Employees
8,233

News

Your note

Sign in to keep a note on BAK — it syncs with the Stock Master app.

Institution ownership

BAK institution ownership
Holder% heldSharesValueReported
LPL Financial Corp0.20%777,1270Mar 30, 2026
Marshall Wace Asset Management Ltd0.17%680,3990Mar 30, 2026
Vanguard Group Inc0.14%560,4660Dec 30, 2025
Brooklands Fund Management Limited0.14%550,0000Mar 30, 2026
Jane Street Group LLC0.13%518,8250Mar 30, 2026
X-Square Capital, LLC0.13%500,9000Mar 30, 2026

Fund ownership

BAK fund ownership
Holder% heldSharesValueReported
State Street® SPDR® Portfolio EM ETF0.08%325,0220May 28, 2026
Vanguard Emerging Mkts Stock Idx Inv0.07%272,4130Apr 29, 2026
Vanguard Total Intl Stock Index Inv0.05%213,2660Apr 29, 2026
Avantis Emerging Markets Equity ETF0.02%90,5920May 29, 2026
Latin America Opportunities B GBP AccH0.01%51,6000Jan 30, 2026
COLOLO Latin American Equity USD R0.01%45,4920May 30, 2026
Advertisement